Royal Bank of Canada’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5K Sell
1,461
-3,849
-72% -$15.8K ﹤0.01% 6421
2025
Q4
$18K Buy
5,310
+3,793
+250% +$9.85K ﹤0.01% 6110
2025
Q3
$2K Sell
1,517
-8,709
-85% -$9.01K ﹤0.01% 6884
2025
Q2
$8K Sell
10,226
-28,999
-74% -$22.8K ﹤0.01% 6534
2025
Q1
$58K Buy
39,225
+26,313
+204% +$62.7K ﹤0.01% 5513
2024
Q4
$58K Sell
12,912
-2,225
-15% -$9.03K ﹤0.01% 5613
2024
Q3
$63K Buy
15,137
+1,134
+8% +$6.1K ﹤0.01% 5591
2024
Q2
$92K Buy
14,003
+5,688
+68% +$40.2K ﹤0.01% 5312
2024
Q1
$72K Sell
8,315
-36,513
-81% -$443K ﹤0.01% 5363
2023
Q4
$513K Buy
44,828
+22,210
+98% +$220K ﹤0.01% 4240
2023
Q3
$218K Buy
22,618
+9,086
+67% +$89K ﹤0.01% 4716
2023
Q2
$144K Buy
13,532
+3,922
+41% +$42.2K ﹤0.01% 5037
2023
Q1
$100K Sell
9,610
-16,400
-63% -$184K ﹤0.01% 5183
2022
Q4
$322K Buy
26,010
+21,946
+540% +$249K ﹤0.01% 4476
2022
Q3
$42K Sell
4,064
-1,852
-31% -$21K ﹤0.01% 5822
2022
Q2
$69K Sell
5,916
-8,901
-60% -$105K ﹤0.01% 5560
2022
Q1
$186K Sell
14,817
-26,918
-64% -$309K ﹤0.01% 5156
2021
Q4
$487K Sell
41,735
-11,375
-21% -$140K ﹤0.01% 4478
2021
Q3
$693K Buy
53,110
+26,006
+96% +$336K ﹤0.01% 4057
2021
Q2
$349K Buy
27,104
+22,883
+542% +$262K ﹤0.01% 4588
2021
Q1
$47K Buy
4,221
+2,363
+127% +$25K ﹤0.01% 5922
2020
Q4
$21K Sell
1,858
-216
-10% -$2.36K ﹤0.01% 6039
2020
Q3
$18K Buy
2,074
+280
+16% +$2.78K ﹤0.01% 5731
2020
Q2
$19K Sell
1,794
-637
-26% -$6.52K ﹤0.01% 5615
2020
Q1
$25K Sell
2,431
-2,176
-47% -$25.6K ﹤0.01% 5447
2019
Q4
$61K Buy
4,607
+2,629
+133% +$29K ﹤0.01% 5348
2019
Q3
$16K Sell
1,978
-162
-8% -$1.57K ﹤0.01% 5596
2019
Q2
$23K Sell
2,140
-373
-15% -$4.18K ﹤0.01% 5645
2019
Q1
$29K Sell
2,513
-677
-21% -$7.56K ﹤0.01% 5462
2018
Q4
$28K Sell
3,190
-6,651
-68% -$76.3K ﹤0.01% 5414
2018
Q3
$153K Buy
9,841
+5,467
+125% +$86.4K ﹤0.01% 4621
2018
Q2
$71K Sell
4,374
-3,090
-41% -$45.7K ﹤0.01% 4994
2018
Q1
$97K Sell
7,464
-264
-3% -$3.29K ﹤0.01% 4714
2017
Q4
$97K Sell
7,728
-10,742
-58% -$140K ﹤0.01% 4834
2017
Q3
$243K Buy
18,470
+15,118
+451% +$208K ﹤0.01% 4379
2017
Q2
$53K Sell
3,352
-1,243
-27% -$18.1K ﹤0.01% 5090
2017
Q1
$66K Sell
4,595
-6,620
-59% -$90.5K ﹤0.01% 5000
2016
Q4
$143K Buy
11,215
+9,245
+469% +$117K ﹤0.01% 4687
2016
Q3
$26K Hold
1,970
﹤0.01% 5439
2016
Q2
$22K Hold
1,970
﹤0.01% 5467
2016
Q1
$18K Sell
1,970
-45
-2% -$371 ﹤0.01% 5529
2015
Q4
$19K Sell
2,015
-1,406
-41% -$13.6K ﹤0.01% 5734
2015
Q3
$31K Buy
3,421
+1,212
+55% +$11.3K ﹤0.01% 5375
2015
Q2
$23K Buy
2,209
+179
+9% +$2.08K ﹤0.01% 5627
2015
Q1
$27K Sell
2,030
-6,447
-76% -$84.6K ﹤0.01% 5226
2014
Q4
$109K Buy
8,477
+595
+8% +$6.81K ﹤0.01% 4690
2014
Q3
$86K Buy
7,882
+6,449
+450% +$73.8K ﹤0.01% 4691
2014
Q2
$18K Sell
1,433
-1,791
-56% -$19.5K ﹤0.01% 5231
2014
Q1
$33K Sell
3,224
-1,552
-32% -$17.5K ﹤0.01% 5026
2013
Q4
$47K Sell
4,776
-1,390
-23% -$12.5K ﹤0.01% 4913
2013
Q3
$62K Buy
6,166
+1,987
+48% +$19.5K ﹤0.01% 4719
2013
Q2
$35K Buy
+4,179
New +$50.7K ﹤0.01% 4823

Other funds holding IRWD

Royal Bank of Canada's IRWD Position: Q1 2026 in Review

Royal Bank of Canada reduced its Ironwood Pharmaceuticals (IRWD) stake by 72% in Q1 2026, selling an estimated $15.8K and leaving 1,461 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6421.

Royal Bank of Canada first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $693K in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Royal Bank of Canada held 1,461 shares of Ironwood Pharmaceuticals worth $5K as of Q1 2026.
  • Royal Bank of Canada sold 3,849 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $15.8K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6421 holding.
  • Royal Bank of Canada first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Ironwood Pharmaceuticals position peaked at $693K in Q3 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.